ALEC

Alector, Inc.

Biotechnology · Biotechnology

$199.11 sample

+3.41 (+1.74%) 1D

Market cap

$1.24T

Price as of

2026-10-23

Latest filing

8-K · 2026-09-09

Alerts

8

Price$199.11 +9.45% 3M daily closessample

199.11173.56

2026-07-282026-08-192026-09-102026-10-012026-10-23

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 21INSInsider buy: Chief Financial Officer
Oct 13INSInsider buy: EVP, Operations
Oct 02INSInsider sell: Chief Executive Officer
Sep 24INSInsider sell: EVP, Operations
Sep 18INSInsider buy: EVP, Operations
Sep 09SEC8-K filed: material event
Sep 02SECForm 144 filed
Aug 26SEC8-K filed: material event

Sign up to see the real ALEC record →

Company facts

SEC EDGAR registration

Name: Alector, Inc.
Sector: Biotechnology
Industry: Biotechnology
Smart-money score: -9sample, -100 to +100
Reporting currency: USD

Who is positioning in ALEC

sample

Insiders: 29 insider transactions over 90 days, net selling, $596.0M
Congress: 2 members traded over 90 days
Institutions · 13F: 14 funds hold $23.3B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$68.0B +15.8% y/y

Q4 2024Q3 2026

Inventory$38.6B +3.4% y/y

Q4 2024Q3 2026

Accounts receivable$28.6B +12.8% y/y

Q4 2024Q3 2026

Total debt$77.1B +5.9% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $700.7B +11.0% 3M
Sample peer B: $228.6B +5.5% 3M
Sample peer C: $440.5B -1.1% 3M
Sample peer D: $656.8B -9.4% 3M
Sample peer E: $671.4B -12.8% 3M